Carolyn Myers
Fortune : 153 506 $ au 31/05/2026
Fortune : 153 506 $ au 31/05/2026
Carolyn J.
Myers is currently President, Chief Executive Officer & Director at FendX Technologies, Inc. since 2020.
Dr. Myers is also a Director at EyeD Pharma SA, Principal at Bio Ensemble Ltd., Committee Member and principal at Mid Atlantic Bio Angels LLC, and Principal at Bioensemble LLC since 2017.
Former roles include Global Director-Cardiovascular at Pharmacia, Inc., Non-Executive Director at Mayne Pharma Group Ltd. from 2021 to 2023, Independent Non-Executive Director at Hyloris Pharmaceuticals SA, Vice President at Mylan Laboratories, Inc. from 2003 to 2007, President at Mylan Specialty LP, President-Specialty Pharmaceutical Division at Mylan, Inc., President at Mylan Technologies, Inc. from 2006 to 2007, President at Dey Laboratories, Inc., Vice President-CNS Marketing at Forest Laboratories, Inc. from 2011 to 2013, and Vice President-Global Business Development at Allergan UC from 2011 to 2017.
Education includes an MBA from Rutgers State University of New Jersey and a doctorate from the University of British Columbia.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FENDX TECHNOLOGIES, INC. 9,18 % | 19/01/2026 | 857 574 ( 9,18 % ) | 153 506 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| FENDX TECHNOLOGIES INC. | Directeur Général | 28/07/2020 |
EyeD Pharma SA
EyeD Pharma SA Medical SpecialtiesHealth Technology Manufactures and supplies ophthalmology surgical products | Directeur/Membre du Conseil | - |
Bio Ensemble Ltd.
Bio Ensemble Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management and business strategy consulting services for pharmaceutical and healthcare industry | Corporate Officer/Principal | - |
Mid Atlantic Bio Angels
Mid Atlantic Bio Angels Investment ManagersFinance Mid Atlantic Bio Angels invests in companies located across the globe. The firm targets companies operating in the field of Life science sectors and industries. It provides financing for early stage capital requirements with an investment size of USD 0.25 - 1 million. It also participates in co-investment and follow-on rounds. | Private Equity Investor | - |
| Sociétés | Poste | Fin |
|---|---|---|
| MAYNE PHARMA GROUP LIMITED | Directeur/Membre du Conseil | 31/07/2023 |
| ALLERGAN PLC | Corporate Officer/Principal | 01/03/2017 |
| FOREST LABORATORIES, INC. | Corporate Officer/Principal | 01/10/2013 |
Mylan Specialty LP
Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets respiratory disease & allergy treatment products | President | 30/06/2011 |
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Corporate Officer/Principal | 02/10/2007 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 16 |
|---|---|
Forest Laboratories, Inc.
Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products | Health Technology |
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Mylan Specialty LP
Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets respiratory disease & allergy treatment products | Health Technology |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Mylan Technologies, Inc.
Mylan Technologies, Inc. Containers/PackagingProcess Industries Manufactures and distributes transdermal products | Process Industries |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia, Inc. | |
Dey Laboratories, Inc. | |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Mayne Pharma Group Ltd.
Mayne Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which develops and manufactures proprietary and generic products | Health Technology |
Bio Ensemble Ltd.
Bio Ensemble Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management and business strategy consulting services for pharmaceutical and healthcare industry | Commercial Services |
Mid Atlantic Bio Angels
Mid Atlantic Bio Angels Investment ManagersFinance Mid Atlantic Bio Angels invests in companies located across the globe. The firm targets companies operating in the field of Life science sectors and industries. It provides financing for early stage capital requirements with an investment size of USD 0.25 - 1 million. It also participates in co-investment and follow-on rounds. | Finance |
EyeD Pharma SA
EyeD Pharma SA Medical SpecialtiesHealth Technology Manufactures and supplies ophthalmology surgical products | Health Technology |
Hyloris Pharmaceuticals SA
Hyloris Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products by reformulating well-known drugs | Health Technology |
FendX Technologies, Inc.
FendX Technologies, Inc. Industrial SpecialtiesProcess Industries Engages in manufacturing, research, development and distribution of surface protection products | Process Industries |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national